n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Chronic Kidney Failure in 2 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Steinmetz-Späh, J | 1 |
| Arefin, S | 1 |
| Larsson, K | 1 |
| Jahan, J | 1 |
| Mudrovcic, N | 1 |
| Wennberg, L | 1 |
| Stenvinkel, P | 1 |
| Korotkova, M | 1 |
| Kublickiene, K | 1 |
| Jakobsson, PJ | 1 |
| Nasrallah, R | 1 |
| Robertson, SJ | 1 |
| Hébert, RL | 1 |
2 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Chronic Kidney Failure
| Article | Year |
|---|---|
Effects of microsomal prostaglandin E synthase-1 inhibition on resistance artery tone in patients with end stage kidney disease.
Topics: Adrenergic Agents; Arteries; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Etoric | 2022 |
Chronic COX inhibition reduces diabetes-induced hyperfiltration, proteinuria, and renal pathological markers in 36-week B6-Ins2(Akita) mice.
Topics: Albuminuria; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Body Weight; Creatinine; | 2009 |